These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 1716846)

  • 21. Potentiation of bradykinin effects and inhibition of kininase activity in isolated smooth muscle.
    Schaffel R; Rodrigues MS; Assreuy J
    Can J Physiol Pharmacol; 1991 Jul; 69(7):904-8. PubMed ID: 1659490
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibitory effect of cilazaprilat on norepinephrine release induced by renal nerve stimulation in anesthetized dogs.
    Satoh S; Matsuoka T; Suzuki-Kusaba M; Chiba K
    Jpn J Pharmacol; 1988 Oct; 48(2):287-9. PubMed ID: 3210452
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative study on the mechanism of bradykinin potentiation induced by bradykinin-potentiating peptide 9a, enalaprilat and kinin-potentiating peptide.
    Rodrigues MS; Schaffel R; Assreuy J
    Eur J Pharmacol; 1992 Jun; 216(3):357-62. PubMed ID: 1330581
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Angiotensin-converting enzyme inhibition increases human vascular tissue-type plasminogen activator release through endogenous bradykinin.
    Pretorius M; Rosenbaum D; Vaughan DE; Brown NJ
    Circulation; 2003 Feb; 107(4):579-85. PubMed ID: 12566370
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biphasic response to bradykinin in isolated porcine iliac arteries is mediated by bradykinin B1 and B2 receptors.
    Persson K; Andersson RG
    J Cardiovasc Pharmacol; 1998 Feb; 31(2):306-13. PubMed ID: 9475274
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardioprotective effect of angiotensin-converting enzyme inhibition against hypoxia/reoxygenation injury in cultured rat cardiac myocytes.
    Matoba S; Tatsumi T; Keira N; Kawahara A; Akashi K; Kobara M; Asayama J; Nakagawa M
    Circulation; 1999 Feb; 99(6):817-22. PubMed ID: 9989969
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical pharmacology of cilazapril.
    Kleinbloesem CH; Van Brummelen P; Francis RJ; Wiegand UW
    Am J Med; 1989 Dec; 87(6B):45S-49S. PubMed ID: 2532460
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of converting enzyme and neointima formation after vascular injury in rabbits and guinea pigs.
    Clozel JP; Hess P; Michael C; Schietinger K; Baumgartner HR
    Hypertension; 1991 Oct; 18(4 Suppl):II55-9. PubMed ID: 1833324
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological properties of the new non-sulfhydryl angiotensin converting enzyme inhibitor N-[8-amino-1(S)-carboxyoctyl]-L-alanyl-L-proline.
    Shirota M; Kajiwara Y; Iijima M; Kitabatake K
    Arzneimittelforschung; 1990 May; 40(5):515-9. PubMed ID: 2166521
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Angiotensin-converting enzyme inhibitors improve coronary flow reserve in dilated cardiomyopathy by a bradykinin-mediated, nitric oxide-dependent mechanism.
    Nikolaidis LA; Doverspike A; Huerbin R; Hentosz T; Shannon RP
    Circulation; 2002 Jun; 105(23):2785-90. PubMed ID: 12057995
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beneficial effects of inhibition of angiotensin-converting enzyme on ischemic myocardium during coronary hypoperfusion in dogs.
    Kitakaze M; Minamino T; Node K; Komamura K; Shinozaki Y; Mori H; Kosaka H; Inoue M; Hori M; Kamada T
    Circulation; 1995 Aug; 92(4):950-61. PubMed ID: 7641379
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High tissue affinity angiotensin-converting enzyme inhibitors improve endothelial function and reduce infarct size.
    Lazar HL; Bao Y; Rivers S; Colton T; Bernard SA
    Ann Thorac Surg; 2001 Aug; 72(2):548-53; discussion 553-4. PubMed ID: 11515896
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of an alpha-2 adrenoceptor agonist on angiotensin converting enzyme inhibitor-induced hypotension and potentiated allergen-evoked inflammatory skin responses.
    Lindgren BR; Grundström N; Andersson RG
    J Pharmacol Exp Ther; 1988 Jun; 245(3):932-5. PubMed ID: 2898524
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nitric oxide release from rat aortic smooth muscle cells is not attenuated by angiotensin converting enzyme inhibitors.
    Ikeda U; Shimada K
    Eur J Pharmacol; 1994 Nov; 269(3):319-23. PubMed ID: 7534708
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics of intravenous cilazaprilat in normal volunteers.
    Whitehead EM; Walters GE; Williams PE; Johnston GD
    Br J Clin Pharmacol; 1989 Jun; 27(6):873-5. PubMed ID: 2757899
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro effect of cilazaprilat on sodium-potassium transport systems in human erythrocytes.
    Lijnen P
    Methods Find Exp Clin Pharmacol; 1990 Mar; 12(2):91-4. PubMed ID: 2319841
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of renin-angiotensin system blockade in guinea pigs.
    Véniant M; Clozel JP; Hess P; Fischli W
    Hypertension; 1992 Mar; 19(3):255-62. PubMed ID: 1532164
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical pharmacology of cilazapril.
    Kleinbloesem CH; van Brummelen P; Francis RJ; Wiegand UW
    Drugs; 1991; 41 Suppl 1():3-10. PubMed ID: 1712269
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of endothelium-derived hyperpolarizing factor in ACE inhibitor-induced renal vasodilation in vivo.
    Matsuda H; Hayashi K; Wakino S; Kubota E; Honda M; Tokuyama H; Takamatsu I; Tatematsu S; Saruta T
    Hypertension; 2004 Mar; 43(3):603-9. PubMed ID: 14769805
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potentiation by enalaprilat of fenoldopam-evoked natriuresis is due to blockade of intrarenal production of angiotensin-II in rats.
    Chen C; Lokhandwala MF
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Aug; 352(2):194-200. PubMed ID: 7477443
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.